Haemonetics HAE Cash Provided by (Used in) Financing Activity, Including Discontinued Operation
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation at other companies
Other financials
Where this comes from
Reported directly by Haemonetics in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.
The official record: Haemonetics’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →
Ask your AI about Haemonetics's cash provided by (used in) financing activity, including discontinued operation.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Haemonetics's cash provided by (used in) financing activity, including discontinued operation?
- Haemonetics (HAE) reported cash provided by (used in) financing activity, including discontinued operation of -$101.5M in Q1 2026.
- What is the long-term trend for Haemonetics's cash provided by (used in) financing activity, including discontinued operation?
- Over 2 years (2022 to 2026), Haemonetics's cash provided by (used in) financing activity, including discontinued operation has grown at a 238.5% compound annual growth rate (CAGR), from -$15.75M to -$180.49M.
- What does cash provided by (used in) financing activity, including discontinued operation mean?
- This metric measures the net cash flow between the company and its capital providers, including proceeds from debt or equity issuance and payments for dividends or share repurchases. It highlights how the company finances its operations and returns value to shareholders.